CN1278446A - Chinese medicinal composition for cerebrovascular disease, rheumatism and rheumatoid disease - Google Patents

Chinese medicinal composition for cerebrovascular disease, rheumatism and rheumatoid disease Download PDF

Info

Publication number
CN1278446A
CN1278446A CN99115807A CN99115807A CN1278446A CN 1278446 A CN1278446 A CN 1278446A CN 99115807 A CN99115807 A CN 99115807A CN 99115807 A CN99115807 A CN 99115807A CN 1278446 A CN1278446 A CN 1278446A
Authority
CN
China
Prior art keywords
radix
herba
rhizoma
caulis
cerebrovascular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN99115807A
Other languages
Chinese (zh)
Other versions
CN1095674C (en
Inventor
贺云青
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN99115807A priority Critical patent/CN1095674C/en
Publication of CN1278446A publication Critical patent/CN1278446A/en
Application granted granted Critical
Publication of CN1095674C publication Critical patent/CN1095674C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to a Chinese medicine for curing cerebrovascular disease and rheumatic and rheumatoid diseases. Its composition comprises 50-odd pure natural Chinese medicinal materials of gastrodia root, uncaria stem and thorn, raw abalone shell and earthworm, etc., and it possesses the functions of promoting blood circulation and transforming stasis, stanching-blood, expelling wind and eliminating dampness, supplementing liver and kidney and strengthening sinew and bone. It has no toxic side effect, and its curative rate is above 98% and its cost is low.

Description

A kind of herbal composite for the treatment of cerebrovascular and rheumatic and rheumatoid diseases
The present invention relates to a kind of herbal composite (Dragon Lord looses) for the treatment of cerebrovascular and rheumatic and rheumatoid diseases.
The rheumatismal new drug of commercially available mainly treating rheumatism is a lot of, but major part contains hormone, but the period in a medicine pain relieving begins pain again after the drug withdrawal, and dosage time by time greatly can pain relieving, informal dress even can be addicted.The medicine that cures mainly cerebrovascular is also a lot, generally all will reach six months the course of treatment just can take effect, and cure rate is very low.
The object of the present invention is to provide a kind of herbal composite (Dragon Lord looses) for the treatment of cerebrovascular and rheumatic and rheumatoid diseases, short treating period, curative effect is fast, and cures the difficult recurrence in back.
Theory of Chinese medical science is thought: after cerebrovascular such as apoplectic hemiplegia, hemiplegia are the body apoplexy, and the resistance of the brain network stasis of blood, obstruction of collateral caused by windphlegm, blood stasis due to qi deficiency, asthenia of essence and blood is due to the mistake of the two muscles and bones thanks to of Liver and kidney is supported.Rheumatoid is to hold wet infiltration human body in the wind under the arm, wet impaction expectorant, and obstruction of collateral caused by windphlegm makes due to the resistance of QI and blood numbness.The inventor thinks that apoplexy is identical with the rheumatoid cause of disease, but is subjected to the position difference of pathogenic factor infringement, and it mainly is brain that apoplexy is subjected to the position of pathogenic factor infringement, and it mainly is limbs joint that rheumatoid is subjected to the position of pathogenic factor infringement, is reflected in just to have occurred different symptoms clinically.Therefore the inventor is according to the etiology and pathogenesis of two kinds of diseases, clinical symptoms, and in addition dialectical Analyses thinks that Therapeutic Method should be identical, according to blood circulation promoting competent silt, attacks expectorant to dispel the wind, relaxing muscles and tendons and activating QI and blood in the collateral, removing damp and stopping pain are main Therapeutic Principle.Why also do not have up to now to cure apoplexy, rheumatoid medicine, the inventor thinks that main cause is that medicine is not used, kind surplus the medicine of modern Chinese medicine voluminous dictionary record has 6000, be used for kind of a medicine surplus 400 clinical and have only in the prior art, up to now also find no the people and exceed routine and remove to open up, test, utilize some new medicines, cause that apoplexy, rheumatoid disease are not had new breakthrough on therapeutic effect.Caulis Erycibes among the side of the present invention, Herba Paederiae, Acer buergerianum Miq, geranium, Herba Sarcandrae, Herba Aristolochiae Mollissimae, Herba Aristolochiae, Caulis Trachelospermi, Caulis Sinomenii, valley dragon have all exceeded the scope of kind of medication surplus in the of conventional 400, thereby make apoplexy, rheumatoid curative effect that new breakthrough arranged.
The present invention is formed by 50 pleasant impression pure natural Chinese herbal medicine compatibilities.Rhizoma Gastrodiae in the side, the structure fourth, Concha Haliotidis, Pheretima, Bombyx Batryticatus, Scorpio, Scolopendra, Herba speranskiae tuberculatae, the valley dragon, Radix Solani Melongenae, Zaocys, Folium Photiniae (Folium Photiniae serrulatae), Agkistrodon, process Radix Aconiti, Radix Aconiti Kusnezoffii Preparata, Radix Angelicae Pubescentis, Cortex Acanthopancis, Fructus Chaenomelis, Radix Gentianae Macrophyllae, CHENGLINGXIAN, Bombyx mori L. Herba Siegesbeckiae, Caulis Piperis Kadsurae, Ramulus Mori, Rhizoma Homalomenae, Herba Lycopodii, Rhizoma Atractylodis, Radix Stephaniae Tetrandrae, Rhizoma Panacis japonici, geranium, Caulis Sinomenii, Herba Aristolochiae Mollissimae, Herba Paederiae, Caulis Erycibes, Semen Strychni (processed), Acer buergerianum Miq, Herba Sarcandrae, Herba Aristolochiae, the Caulis Trachelospermi compatibility has very strong expelling wind and removing dampness, the removing obstruction in the collateral to relieve pain effect; Flos Carthami, Lignum Sappan, Radix Salviae Miltiorrhizae, Niu Xi, Cortex Moutan, Rhizoma Chuanxiong, Myrrha, Olibanum, Squama Manis, Hirudo, Caulis Spatholobi compatibility are the optimal drug of blood nourishing acupuncture-stimulating, blood circulation promoting and blood stasis dispelling; The Cortex Eucommiae, Rhizoma Cibotii, Herba Epimedii, Radix Dipsaci, Rhizoma Curculiginis, Rhizoma Drynariae, Fructus Broussonetiae, Semen Astragali Complanati compatibility have the effect of very strong invigorating the liver and kidney, nourishing muscle and tendon bone; Sha Ruishi, Lignum Dalbergiae Odoriferae, Folium Callicarpae Formosanae, Radix Notoginseng, Radix Rubiae compatibility have the hemostasia and dissipation blood stasis effect of extra-heavy, and be excellent to the period of disease and the sequela curative effect of cerebral hemorrhage.
Composition weight ratio of the present invention is: Rhizoma Gastrodiae 15~50, structure fourth 15~50, Concha Haliotidis 15~50, Pheretima 15~50 Bombyx Batryticatus 15~50, Scorpio 10~40, Scolopendra 10~30, Herba speranskiae tuberculatae 15~50 valley dragons 15~50, Radix Solani Melongenae 15~50, Zaocys 15~50, Folium Photiniae (Folium Photiniae serrulatae) 15~50 Agkistrodons 10~50, process Radix Aconiti 5~25, Radix Aconiti Kusnezoffii Preparata 5~25, Radix Angelicae Pubescentis 15~50 Cortex Acanthopanciss 15~50, Fructus Chaenomelis 15~50, Radix Gentianae Macrophyllae 15~50, Radix Clematidis 15~50 Bombyx mori L.s 15~50 Herba Siegesbeckiaes 15~50, Caulis Piperis Kadsurae 15~50, Ramulus Mori 15~50 Rhizoma Homalomenaes 15~50, Herba Lycopodii 15~50, Rhizoma Atractylodis 15~50, Radix Stephaniae Tetrandrae 10~50 Rhizoma Panacis japonici 15~50, geranium 10~50, Caulis Sinomenii 10~50, Herba Aristolochiae Mollissimae 10~50 Herba Paederiaes 10~50, Caulis Erycibes 10~50, Semen Strychni (processed) 0.5~5, Flos Carthami 5~50 Lignum Sappans 5~50, cattle sunset 10~50, Radix Salviae Miltiorrhizae 10~50, Cortex Moutan 10~50 Rhizoma Chuanxiongs 10~50, Myrrha 10~50, Olibanum 10~50, Squama Manis 10~50 Hirudos 10~40, Caulis Spatholobi 10~50, the Cortex Eucommiae 10~50, Rhizoma Curculiginis 10~50 Rhizoma Cibotii 10~50, Radix Dipsaci 10~50, Rhizoma Drynariae 10~50, Herba Epimedii 10~50 Fructus Broussonetiaes 10~100, Semen Astragali Complanati 10~100, Acer buergerianum Miq 10~50, Herba Sarcandrae 10~50 Herba Aristolochiaes 10~50, Caulis Trachelospermi 10~50.
The following medicine that also can add same weight ratio when treatment cerebral hemorrhage period of disease and sequela: Ophicalcitum 15~100, Lignum Dalbergiae Odoriferae 10~70, Folium Callicarpae Formosanae 10~50, Radix Notoginseng 10~100 Radix Rubiaes 20~100.
The present invention forms with the principle compatibility of the theory of Chinese medical science mutual reinforcement between mutual-assistance, reaches blood circulation promoting and blood stasis dispelling jointly, hemostasis expelling wind and removing dampness, removing obstruction in the collateral to relieve pain, invigorating the liver and kidney, bone and muscle strengthening effect.Take a 1-2 of the present invention course of treatment through clinical observation, each rheumatoid disease, rheumatoid cure rate are reached more than 98%, cure rate to apoplectic hemiplegia has also reached 98%, have no side effect, short treating period, curative effect are fast, and expense is low, does not recur after the drug withdrawal, can thoroughly cure cerebrovascular and rheumatic and rheumatoid diseases.
Embodiment of the invention 1-3 (unit: g):
1 2 3 20 35 50 25 30 45 20 35 45 15 25 35 20 35 50 15 25 35 20 40 50 15 25 45 25 30 50 15 25 45 20 35 50 10 15 35 20 35 50 25 40 50 15 25 35 15 20 35 17 26 35 10 15 25 15 25 40 25 35 50 15 25 40 20 35 50 15 25 40 25 30 45 20 30 45 35 45 50 15 20 35 20 30 45 20 35 50 15 20 30 17 25 45 10 15 25 15 25 50 20 30 45 25 35 50 20 30 45 0.5 2 4 15 25 50 17 20 45 20 35 50 15 25 35 15 25 45 25 30 50 15 25 45 20 35 50 25 30 45 20 35 40 10 20 35 15 25 40 17 30 50 12 20 45 15 25 30 17 30 45 15 25 50 15 20 35 18 25 30 17 30 45 15 40 50 35 50 25 35 20 45 25 50 35 50
Preparation method: every flavor prescription solely pulverized be coarser powder, press mixing behind the desired content compatibility, the plastic bag sealing of packing into after packing with gauze by unit dose 400~500g then gets final product.In order to keep the pure natural drug effect, the moistening of preferably medicine being sprayed water before the pulverizing is to avoid the drug effect of volatilizing in the grinding and processing process.When taking unit dose medicated powder added in marmite that boiled water is an amount of to be soaked five minutes, exchange uniform for three times at a simmer, make about medicinal liquid 2500ml, clothes were three times on 1st, each 100ml, and taking medicine before meal usefulness, taking three months is a course of treatment, can cure general 1-2 course of treatment.

Claims (2)

1, a kind of herbal composite for the treatment of cerebrovascular and rheumatic and rheumatoid diseases is characterized in that the composition weight ratio of described herbal composite is:
Rhizoma Gastrodiae 15~50, structure fourth 15~50, Concha Haliotidis 15~50, Pheretima 15~50
Bombyx Batryticatus 15~50, Scorpio 10~40, Scolopendra 10~30, Herba speranskiae tuberculatae 15~50
Valley dragon 15~50, Radix Solani Melongenae 15~50, Zaocys 15~50, Folium Photiniae (Folium Photiniae serrulatae) 15~50
Agkistrodon 10~50, process Radix Aconiti 5~25, Radix Aconiti Kusnezoffii Preparata 5~25, Radix Angelicae Pubescentis 15~50
Cortex Acanthopancis 15~50, Fructus Chaenomelis 15~50, Radix Gentianae Macrophyllae 15~50, Radix Clematidis 15~50
Bombyx mori L. 15~50, Herba Siegesbeckiaes 15~50, Caulis Piperis Kadsurae 15~50, Ramulus Mori 15~50
Rhizoma Homalomenae 15~50, Herba Lycopodii 15~50, Rhizoma Atractylodis 15~50, Radix Stephaniae Tetrandrae 10~50
Rhizoma Panacis japonici 15~50, geranium 10~50, Caulis Sinomenii 10~50, Herba Aristolochiae Mollissimae 10~50
Herba Paederiae 10~50, Caulis Erycibes 10~50, Semen Strychni (processed) 0.5~5, Flos Carthami 5~50
Lignum Sappan 5~50, cattle sunset 10~50, Radix Salviae Miltiorrhizae 10~50, Cortex Moutan 10~50
Rhizoma Chuanxiong 10~50, Myrrha 10~50, Olibanum 10~50, Squama Manis 10~50
Hirudo 10~40, Caulis Spatholobi 10~50, the Cortex Eucommiae 10~50, Rhizoma Curculiginis 10~50
Rhizoma Cibotii 10~50, Radix Dipsaci 10~50, Rhizoma Drynariae 10~50, Herba Epimedii 10~50
Fructus Broussonetiae 10~10, Semen Astragali Complanati 10~100, Acer buergerianum Miq 10~50, Herba Sarcandrae 10~50
Herba Aristolochiae 10~50, Caulis Trachelospermi 10~50.
2, a kind of herbal composite for the treatment of cerebrovascular and rheumatic and rheumatoid diseases according to claim 1 is characterized in that also can adding in the described herbal composite the following medicine of same weight ratio:
Ophicalcitum 15~100, Lignum Dalbergiae Odoriferae 10~70, Folium Callicarpae Formosanae 10~50, Radix Notoginseng 10~100
Radix Rubiae 20~100.
CN99115807A 1999-06-18 1999-06-18 Chinese medicinal composition for cerebrovascular disease, rheumatism and rheumatoid disease Expired - Fee Related CN1095674C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN99115807A CN1095674C (en) 1999-06-18 1999-06-18 Chinese medicinal composition for cerebrovascular disease, rheumatism and rheumatoid disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN99115807A CN1095674C (en) 1999-06-18 1999-06-18 Chinese medicinal composition for cerebrovascular disease, rheumatism and rheumatoid disease

Publications (2)

Publication Number Publication Date
CN1278446A true CN1278446A (en) 2001-01-03
CN1095674C CN1095674C (en) 2002-12-11

Family

ID=5278719

Family Applications (1)

Application Number Title Priority Date Filing Date
CN99115807A Expired - Fee Related CN1095674C (en) 1999-06-18 1999-06-18 Chinese medicinal composition for cerebrovascular disease, rheumatism and rheumatoid disease

Country Status (1)

Country Link
CN (1) CN1095674C (en)

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1679058A1 (en) * 2003-09-23 2006-07-12 Tianjin Tasly Pharmaceutical Co., Ltd. Pharmaceutical composition for the treatment of angiocardiopathy
CN100344315C (en) * 2005-06-03 2007-10-24 江苏康缘药业股份有限公司 Medicinal composition for promoting bone fracture healing and its preparing method
CN102225125A (en) * 2011-06-21 2011-10-26 马玉伟 Externally applied traditional Chinese medicine composite for treating joint pain caused by rheumatoid arthritis and preparation method thereof
CN102357173A (en) * 2011-10-21 2012-02-22 于明儒 Traditional Chinese medicine formula for curing rheumatism
CN101708322B (en) * 2009-12-09 2012-02-22 邓仁清 Rheumatism-treating medicinal liquor
CN102370731A (en) * 2011-10-27 2012-03-14 牛高峰 Medicament for treating prolapse of lumbar intervertebral disc, hyperosteogeny and hydrarthrosis and preparation method thereof
CN102805824A (en) * 2012-08-25 2012-12-05 兰恒志 Drug for curing apoplexy and preparation method thereof
CN102961558A (en) * 2012-12-11 2013-03-13 楚雄蕴萃生物科技有限公司 Patch and preparation method thereof
CN103655993A (en) * 2013-12-10 2014-03-26 刘萍 Traditional Chinese medicine for treating apoplexy and preparation method thereof
CN103751545A (en) * 2014-01-12 2014-04-30 于秀莲 Traditional Chinese medicinal preparation for treating IgA nephropathy due to deficiency of both qi and yin
CN103798735A (en) * 2014-03-07 2014-05-21 哈尔滨灵椿味道食品开发有限公司 Cassia twig hot-pot flavoring capable of warming channels and dredging collaterals and production method thereof
CN104288519A (en) * 2014-10-28 2015-01-21 李云鹏 Blood circulation-activating and pain-alleviating ointment
CN104587437A (en) * 2015-01-31 2015-05-06 陈西初 Plaster for treatment of stroke paralysis and preparation method thereof
CN105125732A (en) * 2015-09-11 2015-12-09 李传义 Traditional Chinese medicinal powder for rheumatism and preparation method of traditional Chinese medicinal powder
CN106723633A (en) * 2016-11-18 2017-05-31 安徽省天和鞋服有限责任公司 A kind of Health care cloth shoes with alleviation rheumatalgia pain function and preparation method thereof

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101700360B (en) * 2009-09-12 2012-05-09 高兴亮 Chinese medicine prescription for curing bi syndrome

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1163118A (en) * 1996-04-23 1997-10-29 张文胜 Chinese drug preparation for curing diseases of cardio-cerebral vascular system
CN1147950A (en) * 1996-04-30 1997-04-23 郭约翰 Oral liquor for treating and preventing cerebrovascular disease

Cited By (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1679058A1 (en) * 2003-09-23 2006-07-12 Tianjin Tasly Pharmaceutical Co., Ltd. Pharmaceutical composition for the treatment of angiocardiopathy
EP1679058A4 (en) * 2003-09-23 2009-12-09 Tianjin Tasly Pharmaceutical Pharmaceutical composition for the treatment of cardiovascular and cerebrovascular diseases
CN100344315C (en) * 2005-06-03 2007-10-24 江苏康缘药业股份有限公司 Medicinal composition for promoting bone fracture healing and its preparing method
CN101708322B (en) * 2009-12-09 2012-02-22 邓仁清 Rheumatism-treating medicinal liquor
CN102225125A (en) * 2011-06-21 2011-10-26 马玉伟 Externally applied traditional Chinese medicine composite for treating joint pain caused by rheumatoid arthritis and preparation method thereof
CN102225125B (en) * 2011-06-21 2013-06-05 马玉伟 Externally applied traditional Chinese medicine composite for treating joint pain caused by rheumatoid arthritis and preparation method thereof
CN102357173A (en) * 2011-10-21 2012-02-22 于明儒 Traditional Chinese medicine formula for curing rheumatism
CN102357173B (en) * 2011-10-21 2014-04-02 于明儒 Traditional Chinese medicine formula for curing rheumatism
CN102370731A (en) * 2011-10-27 2012-03-14 牛高峰 Medicament for treating prolapse of lumbar intervertebral disc, hyperosteogeny and hydrarthrosis and preparation method thereof
CN102370731B (en) * 2011-10-27 2014-01-29 姜永兰 Medicament for treating prolapse of lumbar intervertebral disc, hyperosteogeny and hydrarthrosis and preparation method thereof
CN102805824B (en) * 2012-08-25 2013-10-30 兰恒志 Drug for curing apoplexy and preparation method thereof
CN102805824A (en) * 2012-08-25 2012-12-05 兰恒志 Drug for curing apoplexy and preparation method thereof
CN102961558A (en) * 2012-12-11 2013-03-13 楚雄蕴萃生物科技有限公司 Patch and preparation method thereof
CN103655993A (en) * 2013-12-10 2014-03-26 刘萍 Traditional Chinese medicine for treating apoplexy and preparation method thereof
CN103655993B (en) * 2013-12-10 2015-10-21 刘萍 A kind of Chinese medicine for the treatment of apoplexy and preparation method thereof
CN103751545A (en) * 2014-01-12 2014-04-30 于秀莲 Traditional Chinese medicinal preparation for treating IgA nephropathy due to deficiency of both qi and yin
CN103798735A (en) * 2014-03-07 2014-05-21 哈尔滨灵椿味道食品开发有限公司 Cassia twig hot-pot flavoring capable of warming channels and dredging collaterals and production method thereof
CN104288519A (en) * 2014-10-28 2015-01-21 李云鹏 Blood circulation-activating and pain-alleviating ointment
CN104587437A (en) * 2015-01-31 2015-05-06 陈西初 Plaster for treatment of stroke paralysis and preparation method thereof
CN105125732A (en) * 2015-09-11 2015-12-09 李传义 Traditional Chinese medicinal powder for rheumatism and preparation method of traditional Chinese medicinal powder
CN106723633A (en) * 2016-11-18 2017-05-31 安徽省天和鞋服有限责任公司 A kind of Health care cloth shoes with alleviation rheumatalgia pain function and preparation method thereof

Also Published As

Publication number Publication date
CN1095674C (en) 2002-12-11

Similar Documents

Publication Publication Date Title
CN100402066C (en) Plaster for treating rheumatism and osteoarthrosis
CN102091202B (en) Traditional Chinese medicinal composition for treating fracture and preparation method thereof
CN103156972B (en) Traditional Chinese medicine combination for treating fracture, hairline fracture and traumatic injury
CN1947790A (en) Medicine for treating paralysis and its prepn. method
CN100998838A (en) Chinese medicine for relaxing muscles and tendons to promote blood circulation preparation method thereof
CN1278446A (en) Chinese medicinal composition for cerebrovascular disease, rheumatism and rheumatoid disease
CN1204523A (en) Prescription of dispelling wind and strengthening bone wine and preparation method
CN1211103C (en) Oral taken and external use medicine for antirheumatism and stopping numbness pain
CN102100872A (en) Chinese medicine preparation for treating mastitis
CN101229355A (en) Rheumatism soup
CN1085089C (en) Traditional Chinese medicine for promoting blood circulation by removing blood stasis
CN1478525A (en) Medicated wine for treating traumatic injury
CN101138625A (en) Chinese medicine composition for treating omarthritis
CN1169563C (en) Strengthening-bone bills contg. cortex Eucommiae for treating RD
CN1063650C (en) Chinese medicinal pill for curing rheumatism and rheumatoid disease and its preparation method
CN104740450A (en) Traditional Chinese medicine foot bath powder for treating rheumatism and preparation and application method of traditional Chinese medicine foot bath powder
CN1186056C (en) Medicine for treating osteoproliferation
CN1698801A (en) Capsule for treating hemiplegia and rheumatism
CN101485826A (en) Chinese medicament preparation for treating rheumatism and rheumatoid disease
CN1241602C (en) Oral administered medicated wine for treating cardiovascular and cerebrovascular diseases
CN108888736B (en) External-use bone reunion medicine and preparation method thereof
CN102058813B (en) Health protection pill for nourishing kidney and spleen and preventing yang deficiency and preparation method thereof
CN105998302A (en) Foot bath powder for treating arthritis and preparation method of foot bath powder
CN106620013A (en) Foot bath powder for treating rheumatoid arthritis, and preparation method of foot bath powder
CN105663850A (en) Traditional Chinese medicine composition for treating oral ulcer

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee